Free shipping on all orders over $ 500

Tasquinimod

Cat. No. M9633
Tasquinimod Structure
Synonym:

ABR-215050

Size Price Availability Quantity
5mg USD 120  USD120 In stock
10mg USD 180  USD180 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tasquinimod is an oral antiangiogenic and S100A9 inhibitor. Tasquinimod allosteric binding at 10-30 nM Kd in the zinc-regulated domain of HDAC4 inhibits co-localization of N-Cor /HDAC3, thereby inhibiting deacetylation of histones and HDAC4-client transcription factors such as HIF-1α. TAMs secretes angiogenic factors such as VEGF, FGF, TNF- α and TGF-β when bone marrow is derived to inhibit cell differentiation. Tasquinimod inhibits tumor angiogenesis by inhibiting tumor invasion of S100A9/ TLR4-dependent MDSCs and/or by inhibiting HIF-1α deacetylation of HDAC4/ N-COR/HDAC3-dependent MDSCs to TAMs. Tasquinimod is an orally active quinoline-3-carboxylamide that binds with high affinity to HDAC4 and S100A9 in cancer and infiltrates host cells in the impaired tumor microenvironment, inhibiting an adaptive survival pathway required for angiogenic responses.

Chemical Information
Molecular Weight 406.36
Formula C20H17F3N2O4
CAS Number 254964-60-8
Solubility (25°C) DMSO ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Martin Pelletier, et al. Blood Adv. Quinoline-3-carboxamides such as tasquinimod are not specific inhibitors of S100A9

[2] John T Isaacs, et al. Oncotarget. Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment

[3] John T Isaacs, et al. Cancer Res. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment

Related HDAC Products
Ac-Arg-Gly-Lys(Ac)-AMC

Ac-Arg-Gly-Lys(Ac)-AMC is a substrate for HDAC.

Chlamydocin

Chlamydocin, a fungal metabolite, is a highly potent HDAC inhibitor, with an IC50 of 1.3 nM.

HDAC-IN-30

HDAC-IN-30 is a novel multi-target HDAC inhibitor, including HDAC1 (IC50=13.4 nM),HDAC2 (IC50=28.0 nM), HDAC3 (IC50=9.18 nM), HDAC6 (IC50=42.7 nM), HDAC8 (IC50=131 nM).

Ac-Arg-Gly-Lys(Ac)-AMC acetate

Ac-Arg-Gly-Lys(Ac)-AMC acetate is a substrate for histone deacetylase (HDAC) and can be used in a novel fluorescent assay for HDAC activity.

JPS014 TFA

JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC).

  Catalog
Abmole Inhibitor Catalog




Keywords: Tasquinimod, ABR-215050 supplier, HDAC, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.